WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2017

Feb 22, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2017-02-21

Reporting Person: Malone Daniel (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-02-21	Stock Options (Right to buy)	$83.47	A	4184.00	Acquired	2027-02-21	Common Stock (4184.00)	Direct

Footnotes

F1: This award vests in 4 equal annual installments beginning on 2/21/2018.